Sunvozertinib: clinical trials recruiting now
6
Recruiting trials
5
Conditions studied
2
US states with sites
3
Countries
Phase breakdown
Phase 1 3
Phase 2 4
Phase 3 1
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer · Sunvozertinib for Lung cancer | 6 |
| Non Small Cell Lung Cancer · Sunvozertinib for Non Small Cell Lung Cancer | 4 |
| Lung Cancer Stage III | 1 |
| Mutation | 1 |
| NSCLC | 1 |
Recruiting trials involving Sunvozertinib
- A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)
- A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery
- Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.
- Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC
- Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)
- Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II
Common questions
How many recruiting trials involve Sunvozertinib?
6 recruiting trials across 5 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.